45
Participants
Start Date
March 31, 2015
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
NS2
NS2 ophthalmic drops (0.5%)
Prednisolone acetate ophthalmic suspension (1%)
Mid-Atlantic Retina, Philadelphia
Virginia Eye Consultants, Norfolk
Bascom Palmer Eye Institute, Plantation
Oakland Ophthalmic Surgery, Birmingham
Lifelong Vision Foundation, Chesterfield
Tauber Eye Center, Kansas City
UNMC Stanley Truhlsen Eye Institute, Omaha
Houston Eye Associates, Houston
Colorado Retina Associates,PC, Golden
Hull Eye Center, Lancaster
Eye Center of Southern Connecticut, Hamden
Valley Eye Physicians & Surgeons, Ayer
Ophthalmic Consultants of Boston, Boston
Massachusetts Eye Research and Surgery Institution (MERSI), Waltham
Metropolitan Eye Research & Surgery Institute, Palisades Park
Lead Sponsor
Aldeyra Therapeutics, Inc.
INDUSTRY